Literature DB >> 8327514

Identification of a cDNA for a human high-molecular-weight B-cell growth factor.

J L Ambrus1, J Pippin, A Joseph, C Xu, D Blumenthal, A Tamayo, K Claypool, D McCourt, A Srikiatchatochorn, R J Ford.   

Abstract

Proliferation is necessary for many of the phenotypic changes that occur during B-cell maturation. Further differentiation of mature B cells into plasma cells or memory B cells requires additional rounds of proliferation. In this manuscript, we describe a cDNA for a human B-cell growth factor we call high-molecular-weight B-cell growth factor (HMW-BCGF). Purified HMW-BCGF has been shown to induce B-cell proliferation, inhibit immunoglobulin secretion, and selectively expand certain B-cell subpopulations. Studies using antibodies to HMW-BCGF and its receptor have suggested that HMW-BCGF, while produced by T cells and some malignant B cells, acts predominantly on normal and malignant B cells. The HMW-BCGF cDNA was identified by expression cloning using a monoclonal antibody and polyclonal antisera to HMW-BCGF. Protein produced from the cDNA induced B-cell proliferation, inhibited immunoglobulin secretion, and was recognized in immunoblots by anti-HMW-BCGF antibodies. The amino acid sequence of HMW-BCGF deduced from the cDNA predicts a secreted protein of 53 kDa with three potential N-linked glycosylation sites. The identification of this cDNA will allow further studies examining physiologic roles of this cytokine. We propose to call it interleukin 14.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327514      PMCID: PMC46922          DOI: 10.1073/pnas.90.13.6330

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

1.  IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.

Authors:  G Del Prete; E Maggi; P Parronchi; I Chrétien; A Tiri; D Macchia; M Ricci; J Banchereau; J De Vries; S Romagnani
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

2.  Identification of a receptor for high molecular weight human B cell growth factor.

Authors:  J L Ambrus; C H Jurgensen; E J Brown; P McFarland; A S Fauci
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

Review 3.  Development of the primary antibody repertoire.

Authors:  F W Alt; T K Blackwell; G D Yancopoulos
Journal:  Science       Date:  1987-11-20       Impact factor: 47.728

Review 4.  Molecular aspects of B-lymphocyte activation.

Authors:  A L DeFranco
Journal:  Annu Rev Cell Biol       Date:  1987

5.  Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.

Authors:  D F Jelinek; P E Lipsky
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

Review 6.  Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells.

Authors:  C J Sanderson; H D Campbell; I G Young
Journal:  Immunol Rev       Date:  1988-02       Impact factor: 12.988

7.  B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells.

Authors:  F M Uckun; A S Fauci; N A Heerema; C W Song; S R Mehta; K Gajl-Peczalska; M Chandan; J L Ambrus
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

8.  Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM.

Authors:  T Defrance; B Vanbervliet; J Pène; J Banchereau
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

9.  Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

Authors:  J M Short; J M Fernandez; J A Sorge; W D Huse
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

10.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.

Authors:  M K Spriggs; R J Armitage; L Strockbine; K N Clifford; B M Macduff; T A Sato; C R Maliszewski; W C Fanslow
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.

Authors:  Byung Ha Lee; Adrienne E Gauna; Kaleb M Pauley; Yun-Jong Park; Seunghee Cha
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice.

Authors:  S Vidal; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

Review 3.  Studying Sjögren's syndrome in mice: What is the best available model?

Authors:  Ghada Abughanam; Ola M Maria; Simon D Tran
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-08

4.  Development of a murine model for blastoid variant mantle-cell lymphoma.

Authors:  Richard J Ford; Long Shen; Yen Chiu Lin-Lee; Lan V Pham; Asha Multani; Hai-Jun Zhou; Archito T Tamayo; ChongJie Zhang; Lesleyann Hawthorn; John K Cowell; Julian L Ambrus
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

5.  Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils.

Authors:  X Yuan; A K Downing; V Knott; P A Handford
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

Review 6.  Current concepts: mouse models of Sjögren's syndrome.

Authors:  Tegan N Lavoie; Byung Ha Lee; Cuong Q Nguyen
Journal:  J Biomed Biotechnol       Date:  2010-12-30

7.  Inferring Regulatory Networks From Mixed Observational Data Using Directed Acyclic Graphs.

Authors:  Wujuan Zhong; Li Dong; Taylor B Poston; Toni Darville; Cassandra N Spracklen; Di Wu; Karen L Mohlke; Yun Li; Quefeng Li; Xiaojing Zheng
Journal:  Front Genet       Date:  2020-02-07       Impact factor: 4.599

8.  Temporal histological changes in lacrimal and major salivary glands in mouse models of Sjogren's syndrome.

Authors:  Jingxiu Xuan; Long Shen; Kishore Malyavantham; Oleh Pankewycz; Julian L Ambrus; Lakshmanan Suresh
Journal:  BMC Oral Health       Date:  2013-10-05       Impact factor: 2.757

9.  High TXLNA Expression Predicts Favourable Outcome for Pancreatic Adenocarcinoma Patients.

Authors:  Shuangyu Lv; Guosen Zhang; Longxiang Xie; Zhongyi Yan; Qiang Wang; Yongqiang Li; Lu Zhang; Yali Han; Huimin Li; Yaowu Du; Yanjie Yang; Xiangqian Guo
Journal:  Biomed Res Int       Date:  2020-02-25       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.